<DOC>
	<DOCNO>NCT00108420</DOCNO>
	<brief_summary>The purpose study determine whether prazosin reduce incidence nightmare , sleep disturbance , overall symptom combat trauma-exposed individual PTSD .</brief_summary>
	<brief_title>Prazosin Treatment Combat Trauma PTSD ( Post-Traumatic Stress Disorder ) Nightmares Sleep Disturbance</brief_title>
	<detailed_description>The combat stress-related nightmare sleep disturbance often follow exposure military combat distress frequently persistent symptom impair quality life occupational social ( e.g. , family ) function . One frequently report trouble symptom PTSD trauma-content nightmare . These nighttime symptom notoriously resistant treatment psychotropic medication anxiolytic , SSRIs , sedate antihistamine cyproheptadine . The SSRIs sertraline ( Zoloft® ) paroxetine ( Paxil® ) drug FDA approve PTSD . This approval base modest overall PTSD improvement compare placebo large multicenter trial enrol almost exclusively noncombat trauma subject . Placebo-controlled SSRI trial PTSD combat veteran negative equivocal . Neurobiologic data suggest combat stress-related nightmare sleep disturbance PTSD relate enhanced central nervous system ( CNS ) adrenergic activity , particularly night . Prazosin CNS-active , non-sedating alpha-1 antagonist long generically available treatment hypertension benign prostatic hypertrophy . We recently demonstrate Vietnam combat veteran chronic PTSD prazosin robustly effective previously treatment refractory combat trauma related nightmare , sleep disturbance overall PTSD severity functional impairment . The goal study evaluate efficacy tolerability prazosin compare placebo combat stress-related nightmare , sleep disturbance overall function combat-trauma expose person PTSD . Primary outcome measure Clinical Global Impression Change , Recurrent Distressing Dreams Difficulty Falling Staying Asleep item CAPS , total CAPS ( exclusive dream sleep item ) , Pittsburgh Sleep Quality Index . Depression quality life also assess .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>Combattrauma expose person diagnosis PTSD No diagnosis lifetime schizophrenia , schizoaffective disorder , bipolar disorder , psychotic disorder , DSMIV cognitive disorder ; current delirium , substance dependence disorder within 3 month study current substance use alcohol ( 2 drinks/day ) ; severe psychiatric instability situational life crisis , include evidence actively suicidal homicidal , behavior pose immediate danger patient others In good general medical health ( acute significant chronic medical illness , include unstable angina , recent myocardial infarction , history congestive heart failure , preexist hypotension [ systolic &lt; 110 ] orthostatic hypotension [ systolic drop &gt; 20 mmHg two minute stand drop dizziness ] ; insulindependent diabetes mellitus ; chronic renal hepatic failure , pancreatitis , gout , Meniere 's disease , benign positional vertigo , narcolepsy , allergy previous adverse reaction prazosin alpha1 antagonist , unstable medical condition ) . Stable dose nonexcluded medication concurrent stable medical condition least 4 week prior randomization . Specific criterion use validate presence combat stressrelated nightmare sleep disturbance include : score &gt; 5 ( maximum score 8 ) CAPS Recurrent Distressing Dreams item . ( CAPS score &gt; 5 place subject upper third nightmare severity ) score &gt; 5 ( maximum score 8 ) CAPS Difficulty Falling Staying Asleep item .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Prazosin</keyword>
	<keyword>Stress Disorders , Post-traumatic</keyword>
</DOC>